ETElif Tuğba Tuncel

Elif Tuğba Tuncel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elif Tuğba Tuncel has a total of 689 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative Effectiveness of Vedolizumab and Ustekinumab in Biologic-Experienced Ulcerative Colitis: A Real-World Multicenter Study from the Güntürk Group

    by Filiz Araz, Orhan Sezgin, Sezgin Barutçu, Nalan Gülşen Ünal, Göksel Bengi, Burak Özşeker, Ümit Karaoğullarindan, Gözde Derviş Hakim, Birol Özer, Hale Akpinar, et al.

    Background/Aims: The study aimed to compare the effectiveness and safety of vedolizumab (VDZ) and ustekinumab (UST) in patients with ulcerative colitis (UC) previously exposed to biologic therapy and to determine whether prior biologic exposure affects treatment outcomes. Materials and Methods: In this multicenter retrospective study, data from 420 patients treated at 14 centers with VDZ (n = 260) or UST (n = 160) between 2020 and 2024 were analyzed. Outcomes included steroid-free clinical remission (SFCR), clinical remission (CR), treatment persistence, and adverse events at weeks 14-16, 52, and 104. Inverse probability of treatment weighting was used to adjust for baseline differences between treatment groups. Results: In the weighted cohort, rates of SFCR and CR were comparable between treatments at weeks 14-16 and 52 (P > .05). At week 104, SFCR rates did not differ significantly between treatment groups, whereas VDZ was associated with higher CR rates (adjusted odds ratio [aOR] = 0.66; 95% CI = 0.45-0.91). In subgroup analyses, VDZ was associated with higher CR and SFCR rates among patients with 1 prior biologic exposure, whereas UST was associated with higher CR (aOR = 1.86; 95% CI = 1.10-3.16) and SFCR (aOR = 1.79; 95% CI = 1.05-3.09) rates at week 52 among patients with 2 or more prior biologic exposures. Treatment persistence was significantly higher with UST (aOR = 1.82; 95% CI = 1.36-2.44). Safety profiles were comparable between treatment groups. Conclusion: VDZ and UST demonstrated broadly comparable effectiveness in biologic-experienced UC. The higher CR rate favoring VDZ at week 104 should be interpreted cautiously given the lack of a significant difference in SFCR rate and limitations of long-term followup assessment. Exploratory subgroup findings suggest that UST may have a potential role in patients who were heavily pretreated. These findings may inform hypotheses regarding individualized treatment sequencing. Cite this article as: Araz F, Sezgin O, Barutçu S, et al. Comparative effectiveness of vedolizumab and ustekinumab in biologicexperienced ulcerative colitis: A real-world multicenter study from the GÜNTÜRK group. Turk J Gastroenterol.Published online October 5, 2026. doi: 10.5152/tjg.2026.26102.

  • Open Access

    Gastroenteroloji Textbook - Cilt (1-2)

    by Alper Macif, Ahmed Ramiz Baykan, Gökhan Çoban, Sadık Yavuz, Berk Bas, Mehmet Kasım Aydın, Selçuk Candan, Fatih Güzelbulut, Atilla Bulur, Fatih Ensaroğlu, et al.

  • Open Access

    Gastroenterolojide Sık Konsültasyonlar

    by Özgür Ecemiş, Elif Tuğba Tuncel

    Günlük pratiğimizde ayaktan, yatan, acil servis, ameliyat öncesi, ameliyat sonrası ve yoğun bakım ünitelerindeki hastalardan istenen konsültasyonlarla sık karşılaşmaktayız. Ayaktan başvurular hariç diğer saydığımız kısımlardan istenen konsültasyonlar genelde acil nitelik taşımaktadır. Bu bölümde karın ağrısı, gastrointestinal sistem kanaması, ishal, kabızlık, bulantı ve kusma, karaciğer enzim yüksekliği, gebeliğe özgü karaciğer hastalıkları, hiperamilazemi ve karaciğer hastalıklarında cerrahi değerlendirme başlıkları altında istenen konsültasyonlara yaklaşımı anlattık. Hasta değerlendirirken ilk adım olarak hastaneye başvuru nedeni saptanmalıdır. Sonraki adım etyolojiyi belirlemeye çalışmak olmalıdır. Üçüncü olarak hastalığın ciddiyeti değerlendirilmelidir. Dördüncü olarak istenen konsültasyonla ilgili komplikasyon olup olmadığını araştırmaktır. Konsültasyon formunun öneriler bölümü, hastalığın nedeni ve ciddiyeti için eksik olan tanısal testleri vurgulamalıdır. Buna ek olarak, hastalığın tedavisi, ilişkili komplikasyonlar, prognoz ve tedaviye beklenen yanıtla ilgili bir yorum bulunmalıdır. Bu konulara ve bunların yönetimine en iyi şekilde odaklanan bir konsültasyon raporu, en fazla bilgi ve değeri sağlayacaktır.

  • Open Access

    Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome

    by Elif Tugba Tuncel, Seda Sabah Ozcan, Mehmet Korkmaz, Elif Börekci

    Objective: Inflammation and immunity play major roles in the etiopathogenesis of functional intestinal disorders. The salusins that were identified in this study are important because of their ease of collection, sensitivity and reliability. For that reason, the aim of this study was to analyze the importance of the levels of salusin in the blood, an inflammation-related parameter, in the diagnosis and prediction of irritable bowel disease. Methodology: The study participants included 28 diagnosed with constipation-predominant IBS, 29 (34.1%) diagnosed with diarrhea-predominant IBS (D-IBS), and 28 (32.9%) controls. Enzyme-linked immune-sorbent assay (ELISA) method has been used for the measurement of salusin levels. Results: Participants were 50 (58.8%) female and 35 (41.2%) male. The serum levels of salusin-α were substantially reduced in the diarrhea-predominant IBS group vs controls. There was also no major difference in the levels of salusin between the constipation-predominant-IBS and the diarrhea-predominant IBS group. Conclusion: A major prognostic relationship was found between the level of salusins and the subgroup of D-IBS. It is well known that salusins have been related to inflammatory processes and oxidative injury in previous studies. The relationship between salusin and gastrointestinal diseases should be further investigated. Low-grade submucosal intestinal inflammation is also associated with irritable bowel syndrome. It is our belief that salusins may be useful in diagnosing, predicting or treating IBS.


  • Prognostic Significance of the Hemoglobin-Albumin Ratio in Upper Gastrointestinal Bleeding

    by Elif Tuğba Tuncel, Funda Seher Özalp Ateş

    Objective Upper gastrointestinal bleeding is a serious and life-threatening condition where monitoring and prognosis are crucial. This study aimed to compare the prognostic value of the hemoglobin-albumin ratio (HAR) with endoscopic risk scoring systems. Methods The medical records of 153 patients with upper gastrointestinal bleeding treated at our clinic between 2022 and 2024 were retrospectively reviewed. Endoscopic risk scoring systems, including the Rockall score (RS), Glasgow-Blatchford score (GBS), and Forrest classification, were calculated. The HAR score, consisting of hematologic parameters, was computed. The HAR score was compared with clinical findings and endoscopic scores using the Mann-Whitney U and Kruskal-Wallis tests. The relationships between the HAR values and numerical variables were examined using Spearman’s correlation coefficient. Results Of the patients, 122 (79.7%) were male and 31 (20.3%) were female. A duodenal ulcer was the most common endoscopic finding (43.7%). The mean GBS was 10.69±3.89, RS was 4.37±2.27, and HAR was 2.88±0.64. There was a low-level significant correlation between the HAR score and the Glasgow Blatchford score (r=-0.254, p=0.002). Low hemoglobin levels, a low HAR score, and a high GBS were associated with a poor prognosis. Conclusion In patients with upper gastrointestinal bleeding, a low HAR score is associated with a poor prognosis. The HAR score is an effective and reliable marker, similar to endoscopic scoring systems. This study revealed a correlation between a high GBS and a low HAR score. Due to its simplicity, rapid and easy calculation, and practicality, the HAR score can be used routinely in clinical practice.

  • Comparison of Colonoscopy and Histopathological Findings in Terminal Ileum Lesions

    by Elif Tuğba Tuncel, Selçuk Turgut, Tahir Buran, Elmas Kasap

    Öz Giriş ve Amaç Terminal ileumu etkileyen hastalıklarda kolonoskopi ile terminal ileumun görüntülenmesi ve biyopsi alınması altın standarttır. Bu çalışmada kolonoskopik görünüm ile terminal ileumun histopatolojik bulgularının tanısal açıdan karşılaştırılması amaçlandı. Gereç ve Yöntemler 2014-2023 yılları arasında Celal Bayar Üniversitesi Tıp Fakültesi Gastroenteroloji kliniğinde kolonoskopi yapılan 971 hasta dosyası retrospektif incelenerek veriler toplandı. Hastaların yaş ve cinsiyet gibi demografik verileri kaydedildi. Kolonoskopi raporları ve histopatolojik bulguları değerlendirildi. Sonuçlar Hastaların 457’si (%47 ) kadın, 514’ü (%53) erkekti. Yaş ortalaması 47,7’di. Hem kolonoskopik hem de histopatolojik olarak terminal ileumu normal olan hasta sayısı 562(%57,8)’di. Terminal ileumda hem kolonoskopik hem de histopatolojik olarak en fazla görülen bulgu mukozal ödemdi (%6,1). Kolonoskopide normal terminal ileumu olanlarda histopatolojik olarak ileit saptanma oranı 27(%4) ve ileal ülser olanlarda patolojik olarak kronik inflamatuar barsak hastalığı saptanma oranı ise 28(%49,1)’di. Tartışma Kolonoskopik görünüm ile histopatolojik bulguların anlamlı oranda korele olduğu gösterildi. Bundan dolayı ileal hastalıkların tanısında hem kolonoskopik görünüm hem de histopatolojik bulgular aynı oranda değerlidir. Ayrıca klinik olarak gerekli durumlarda ileum entübasyonu ve histopatolojik değerlendirme mutlaka yapılmalıdır.

  • Gastro İntestinal Sistem Maluliyet Değerlendirilmesi

    by Gökmen Karabağ, Volkan Zeybek, Elif Tuğba Tuncel, Mehmet Sunay Yavuz

  • Open Access

    Maluliyet Kalıcı Bedensel Hasarların Değerlendirilmesi

    by Ebubekir Çetin, Halis Dokgöz, İsMail Özgür Can, Çağdaş Savaş, Şeyma Tuğçe Ünaldı, Orhan Kalemci, Turan Poyraz, Akça Toprak Ergönen, Halil İlhan Aydoğdu, Ramazan Akpınar, et al.

    Maluliyet Tarihine Engellilik Perspektifiyle Yaklaşım Ebubekir CETİN Halis DOKGOZ Kafa Travmaları Maluliyet Değerlendirilmesi İsmail Özgür CAN Çağdaş SAVAŞ Şeyma Tuğçe UNALDI Orhan KALEMCİ Turan POYRAZ Akca Toprak ERGONEN Santral ve Periferik Sinir Sistemi Maluliyet Değerlendirilmesi Halil İlhan AYDOĞDU Ramazan AKPINAR Plastik, Rekonstrüktif ve Estetik Cerrahi Maluliyet Değerlendirilmesi Ceren Gorkem KURT Kenan KAYA Toygun Anıl OZESEN Omer KOKACYA Travma ve Stresörle İlişkili Bozukluklar Maluliyet Değerlendirilmesi Duygu Nur TUTAM Bahadır GENİŞ Başar COLAK Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları Maluliyet Değerlendirilmesi Emre YULUĞ Alperen BIKMAZER Görme Sistemi Maluliyet Değerlendirmesi Abdullah TURAN Nursel Gamsız BİLGİN Humeyra YILDIRIM Kulak Burun Boğaz Hastalıkları Maluliyet Değerlendirilmesi Kadir Serkan ORHAN Emin BİCEN Toraks Travmaları Maluliyet Değerlendirilmesi Abdulkadir YILDIZ Sumeyye FİDANCI Suleyman Serhat GURPINAR Gastro İntestinal Sistem Maluliyet Değerlendirilmesi Gokmen KARABAĞ Volkan ZEYBEK Elif Tuğba TUNCEL Mehmet Sunay YAVUZ Kas İskelet Sistemi Maluliyet Değerlendirilmesi Tuğce KOCA YAVUZ Kenan KAYA Akif MİRİOĞLU Ahmet HİLAL Omurga Yaralanmaları Maluliyet Değerlendirilmesi İbrahim EROĞLU Mehmet Ali MALKOC Mehri GUNER Sedat SEVİCİN Nadir ARICAN Çocuk Olgularda Maluliyet Değerlendirilmesi/ÇÖZGER Muhammet CAN Kubra NURDOĞAN Celal BUTUN Maluliyet Olgularında Radyolojik Değerlendirme Ebru YAŞAT AKSAY Barış TEN Feramuz Demir APAYDIN Nursel GAMSIZ BİLGİN Nöropatik Ağrı, Kronik Ağrı Sendromu ve Maluliyet Değerlendirilmesi Tuğsan Egemen BİLGİN Ali METİN Nursel GAMSIZ BİLGİN Maluliyet ve Temaruz Selin SELEK CIRAKOĞLU Emre CIRAKOĞLU Maluliyet ve Malpraktis Sezer CEKİC Caner BEŞKOC İş Göremezlik Süresi, İyileşme ve Bakıma Muhtaç Kavramlarının Değerlendirilmesi Gökhan AKTURK Nursel GAMSIZ BİLGİN Çalışma Gücü ve Meslekte Kazanma Gücü Kaybı Oranı Tespiti İşlemleri Yönetmeliği İle İlgili Değerlendirme ve Öneriler Mehmet CAVLAK Ramazan AKCAN Aysun BALSEVEN ODABAŞI Ali Rıza TUMER Erişkinler için Engellilik Değerlendirilmesi Hakkında Yönetmelik İle İlgili Değerlendirme ve Öneriler Aysun BARANSEL ISIR Halid EROZ Murat AKBABA Amerikan Hekimler Birliği Kalıcı Maluliyet Değerlendirme Kılavuzunun (AMA) Değerlendirilmesi Şahnur SERAP AYTUĞ Hakan KAR Nursel GAMSIZ BİLGİN Sigorta Tahkim Komisyonu Çalışma Prensipleri ve Komisyonca Yapılan Başvuruların Değerlendirilme Şekilleri Ekin Ozgur AKTAŞ Maluliyet ile İlişkili Yargıtay Kararları Ceren YILDIZ Berna AYDIN Nursel GAMSIZ BİLGİN Maluliyet/Engellilik Raporlarında Tartışmalı, Etik ve Yasal Sorunlar Başar COLAK Ahmet HİLAL Mersin Üniversitesi Adli Tıp Anabilim Dalı Olgu Deneyimleri Nursel GAMSIZ BİLGİN Hakan KAR Halis DOKGOZ Çukurova Üniversitesi Adli Tıp Anabilim Dalı Olgularla Maluliyet Kenan KAYA Ahmet HİLAL


  • Open Access

    Prognostic Relationship Between the ABO Blood Groups and Metastatic Gastric Cancer

    by Elif Tugba Tuncel, Engin Kut

    Aim: Gastric cancer is one of the most common malignant tumors of the digestive system and has a poor prognosis. Since recurrence and distant metastasis are common in gastric cancer, it is important to use practical and reliable prognostic parameters. In this study, the prognostic relationship between the ABO blood groups and metastatic gastric cancer was investigated. Method and Material: Data were collected by retrospectively scanning the files of 225 patients who were followed up with the diagnosis of metastatic gastric cancer in 2010-2022. The patients’ demographic data (age, gender), tumor histopathology, tumor location, and ABO and Rh blood groups were evaluated. Results: Of the patients, 138 (61.3%) were male and 87 (38.7%) were female. According to the distribution of the ABO system, blood group A was present in 109 (48.4%) patients, B in 33 (14.7%), AB in 20 (8.9%), and O in 63 (28%). Signet ring cell carcinoma, antrum tumor localization, and distant metastasis were more common in blood groups A and O. According to both the univariate and multivariate analyses, overall survival (OS) was statistically worse in patients with signet ring cell carcinoma and peritoneal metastasis (p < 0.05). The OS rate was the worst in blood group A and best in blood groups AB and B. Conclusion: In this study, blood group A presented as both a risk factor and a poor prognostic factor in the development of metastatic gastric cancer. In addition, signet ring cell histopathology and presence of metastasis were found to be more common in patients with blood group A and associated with a poor prognosis. Blood groups are inexpensive, easily available, and reliable parameters that can provide an idea about both prognosis and survival in gastric cancer. Therefore, they can serve as a guide for clinicians in the follow-up and evaluation of the prognosis of these patients.


  • Open Access

    Prognostic value of the prognostic nutritional index in severe COVID-19 infection

    by Elif Tugba Tuncel

    Objective: Nutritional status plays an important role in defense against infection. This study aimed to investigate the effect of the prognostic nutritional index (PNI), which consists of inflammation and nutritional markers, on prognosis and survival in patients with severe COVID-19 infection. Material and Methods: Data were retrospectively collected by screening the files of 146 patients diagnosed with COVID-19 infection in 2020 and 2021. The PNI values of the patients were calculated using the obtained data. The cut-off value of PNI was determined with the receiver operating characteristic analysis. Multivariate and univariate analyses were undertaken to evaluate the prognostic value of PNI and its relationship with clinical features and overall survival (OS) in patients with severe COVID-19 infection. Results: The study included a total of 146 patients, of whom 83 (60%) were male, and 55 (39.9%) were female. The mean age was 62 years. The cut-off value of PNI was 45. PNI was found to be associated with prognosis in both univariate and multivariate analyses. Survival and prognosis were statistically significantly better in the group with a PNI higher than the cut-off value (PConclusion: PNI was determined to have independent prognostic value and predict OS in severe COVID-19 infection. The results showed that COVID-19 infection was more severe and had a worse prognosis in the patients with a low PNI (<45). Based on the measurement of simple, inexpensive, and easily available biomarkers, PNI can be beneficial in clinical practice.